A fluorescence in situ hybridization study of complex t(9;22) in two chronic myelocytic leukemia cases with a masked Philadelphia chromosome

Cancer Genetics and Cytogenetics

Volumn 150, Issue 1, 2004, Pages 81-85

  Zagaria, Antonella ^a   Anelli, Luisa ^a   Albano, Francesco ^a   Storlazzi, Clelia Tiziana ^a   Liso, Arcangelo ^a   Roberti, Maria Grazia ^b   Buquicchio, Caterina ^a   Liso, Vincenzo ^a   Rocchi, Mariano ^a   Specchia, Giorgina ^a,b  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF FOGGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BCR ABL PROTEIN; CYTARABINE; ETOPOSIDE; HYDROXYUREA; IDARUBICIN; IMATINIB;

ADULT; ARTICLE; BONE MARROW BIOPSY; CANCER DIAGNOSIS; CASE REPORT; CHROMOSOME 22; CHROMOSOME 9; CHROMOSOME REARRANGEMENT; CHRONIC MYELOID LEUKEMIA; CLINICAL FEATURE; CYTOGENETICS; DEATH; DISEASE COURSE; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY TEST; MALE; MOLECULAR CLONING; MOLECULAR GENETICS; PHILADELPHIA 1 CHROMOSOME; PHYSICAL EXAMINATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

CHROMOSOMES, HUMAN, PAIR 22; CHROMOSOMES, HUMAN, PAIR 8; CHROMOSOMES, HUMAN, PAIR 9; FUSION PROTEINS, BCR-ABL; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LEUKEMIA, MYELOID, CHRONIC; LEUKEMIA, MYELOID, PHILADELPHIA-NEGATIVE; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; MALE; MIDDLE AGED; TRANSLOCATION, GENETIC;

EID: 12144291058     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2003.08.018     Document Type: Article

References (29)

1. Shtivelman E., Lifshitz B., Gale R.P., Canaani E. Fused transcript of abl and bcr genes in chronic myelogenous leukaemia. Nature. 315:1985;550-554.
2. Johansson B., Fioretos T., Mitelman F. Cytogenetic and molecular genetic evolution of chronic myeloid leukemia. Acta Haematol. 107:2002;76-94.
3. Mitelman F, Johansson B, Mertens F, editors. Mitelman database of chromosome aberrations in cancer. Available at: http://www.cgap. nci.nih.gov/Chromosomes/Mitelman. Accessed July 2003.
4. Hagemeijer A., de Klein A., Godde-Salz E., Turc-Carel C., Smit E.M., van Agthoven A.J., Grosveld G.C. Translocation of c-abl1 to "masked" Ph in chronic myeloid leukemia. Cancer Genet Cytogenet. 18:1985;95-104.
5. Fitzgerald P.H., Morris C.M. Complex chromosomal translocations in the Philadelphia chromosome leukemias: serial translocations or a concerted genomic rearrangement? Cancer Genet Cytogenet. 57:1991;143-151.
6. Bartram C.R., Kleihauer E., de Klein A., Grosveld G., Teyssier J.R., Heisterkamp N., Groffen J. C-abl and bcr are rearranged in a Ph1-negative CML patient. EMBO J. 4:1985;683-686.
7. Van der Plas D.C., Hermans A.B., Soekarman D., Smit E.M., de Klein A., Smadja N., Alimena G., Goudsmit R., Grosveld G., Hagemeijer A. Cytogenetic and molecular analysis in Philadelphia negative CML. Blood. 3:1989;1038-1044.
8. Morris C., Kennedy M., Heisterkamp N., Columbano-Green L., Romeril K., Groffen J., Fitzgerald P. A complex chromosome rearrangement forms the BCR-ABL fusion gene in leukemic cells with a normal karyotype. Genes Chromosomes Cancer. 3:1991;263-271.
9. Jadayel D., Calabrese G., Min T., van Rhee F., Swansbury G.J., Dyer M.J., Maitland J., Palka G., Catovsky D. Molecular cytogenetics of chronic myeloid leukemia with atypical t(6;9)(p23;q34) translocation. Leukemia. 9:1995;981-987.
10. Aurich J., Duchayne E., Huguet-Rigal F., Bauduer F., Navarro M., Perel Y., Pris J., Caballin M.R., Dastugue N. Clinical, morphological, cytogenetic and molecular aspects of a series of Ph-negative chronic myeloid leukemias. Hematol Cell Ther. 40:1998;149-158.
11. Sessarego M., Fugazza G., Bruzzone R., Ballestrero A., Miglino M., Bacigalupo A. Complex chromosome rearrangements may locate the bcr/abl fusion gene sites other than 22q11. Haematologica. 85:2000;35-39.
12. Sokal J., Cox E., Baccarani M. Prognostic discrimination in "good risk" chronic granulocytic leukemia. Blood. 63:1984;1352-1357.
13. Hasford J., Pfirrmann M., Hehlmann R., Allan N.C., Baccarani M., Kluin-Nelemans J.C., Alimena G., Steegmann J.L., Ansari H. A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alpha. J Natl Cancer Inst. 90:1998;850-858.
14. Lichter P., Tang Chang C.J., Call K., Hermanson G., Evans G.A., Housman D., Ward D.C. High resolution mapping of human chromosomes 11 by in situ hybridization with cosmid clones. Science. 247:1990;64-69.
15. van Dongen J.J., Macintyre E.A., Gabert J.A., Delabesse E., Rossi V., Saglio G., Gottardi E., Rambaldi A., Dotti G., Griesinger F., Parreira A., Gameiro P., Diaz M.G., Malec M., Langerak A.W., San Miguel J.F., Biondi A. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia. 13:1999;1901-1928.
16. Mitelman F. An international system for human cytogenetic nomenclature. 1995;S. Karger, Basel.
17. Storlazzi C.T., Specchia G., Anelli L., Albano F., Pastore D., Zagaria A., Rocchi M., Liso V. Breakpoint characterization of der(9) deletions in CML patients. Genes Chromosomes Cancer. 35:2002;271-276.
18. Diederich M., Visvikis A., Siest G., Michelet F., Oster T., Courtay C., Wellman M. Gamma-glutamyltransferase: nucleotide sequence of the human pancreatic cDNA. Evidence for a ubiquitous gamma-glutamyltransferase polypeptide in human tissues. Biochem Pharmacol. 43:1992;2527-2533.
19. Xiao J., Liu C.C., Chen P.L., Lee W.H. RINT-1, a novel Rad50-interacting protein, participates in radiation-induced G(2)/M checkpoint control. J Biol Chem. 276:2001;6105-6111.
20. Nagase T., Ishikawa K., Kikuno R., Hirosawa M., Nomura N., Ohara O. Prediction of the coding sequences of unidentified human genes XV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. DNA Res. 6:1999;337-345.
21. Ikegawa S., Isomura M., Koshizuka Y., Nakamura Y. Cloning and characterization of a novel gene (C8orf2), a human representative of a novel gene family with homology to C. elegans C42.C1.9. Cytogenet Cell Genet. 85:1999;227-231.
22. Hild F., Fonatsch C. Cytogenetic peculiarities in chronic myelogenous leukemia. Cancer Genet Cytogenet. 47:1990;197-217.
23. Kadam P.R., Nanjangud G.J., Advani S.H., Nair C., Banavali S., Gopal R., Saikia T. Chromosomal characteristics of chronic and blastic phase of chronic myeloid leukemia. A study of 100 patients in India. Cancer Genet Cytogenet. 51:1991;167-181.
24. Ge X.Q., Tanaka K., Mansyur A., Tazawa H., Iwato K., Kyo T., Dohy H., Kamada N. Possible prediction of myeloid and lymphoid crises in chronic myelocytic leukemia at onset by determining the methylation status of the major breakpoint cluster region. Cancer Genet Cytogenet. 126:2001;102-110.
25. Fischer K., Brown J., Scherer S.W., Schramm P., Stewart J., Fugazza G., Pascheberg U., Peter W., Tsui L.C., Lichter P., Dohner H. Delineation of genomic regions in chromosome band 7q22 commonly deleted in myeloid leukemias. Recent Results Cancer Res. 44:1998;46-52.
26. Tosi S., Scherer S.W., Giudici G., Czepulkowski B., Biondi A., Kearney L. Delineation of multiple deleted regions in 7q in myeloid disorders. Genes Chromosomes Cancer. 25:1999;384-392.
27. Macdonald D., Reiter A., Cross N.C. The 8p11 myeloproliferative syndrome: a distinct clinical entity caused by constitutive activation of FGFR1. Acta Haematol. 107:2002;101-107.
28. Pebusque M.J., Chaffanet M., Popovici C., Birnbaum D. FGFR1 and MOZ, two key genes involved in malignant hemopathies linked to rearrangements within the chromosomal region 8p11-12. Bull Cancer. 87:2000;887-894.
29. Reither A., Hehlmann R., Goldman J.M., Cross N.C. The 8p11 myeloproliferative syndrome. Med Klin. 94:1999;207-210.